Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

Is imaging needed to define remission in rheumatoid arthritis?

New research reports that ultrasonography predicts absence of clinical flare following discontinuation of biologic therapy in patients with rheumatoid arthritis in clinical remission. Other studies also support the inclusion of ultrasonography and MRI in future remission criteria. Ongoing studies to clarify clinical and structural damage benefits of imaging-based treat-to-target strategies are awaited.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Iwamoto, T. et al. Ultrasonographic assessment predicts relapse after discontinuation of biological agents in patients with rheumatoid arthritis in clinical remission. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22303.

  2. Haavardsholm, E. A., Lie, E. & Lillegraven, S. Should modern imaging be part of remission criteria in rheumatoid arthritis? Best Pract. Res. Clin. Rheumatol. 26, 767–785 (2012).

    Article  PubMed  Google Scholar 

  3. Brown, A. K. et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 54, 3761–3773 (2006).

    Article  CAS  PubMed  Google Scholar 

  4. Brown, A. K. et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 58, 2958–2967 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. Foltz, V. et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum. 64, 67–76 (2012).

    Article  PubMed  Google Scholar 

  6. Gandjbakhch, F. et al. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity. J. Rheumatol. 41, 398–406 (2014).

    Article  PubMed  Google Scholar 

  7. Scirè, C. A. et al. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford) 48, 1092–1097 (2009).

    Article  Google Scholar 

  8. Colebatch, A. N. et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum. Dis. 72, 804–814 (2013).

    Article  PubMed  Google Scholar 

  9. Saleem, B. et al. Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Ann. Rheum. Dis. 69, 1636–1642 (2010).

    Article  PubMed  Google Scholar 

  10. Axelsen, M. B. et al. Whole-body MRI assessment of disease activity and structural damage in rheumatoid arthritis: first step towards an MRI joint count. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket425.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mikkel Østergaard.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

Overview of clinical trials of imaging-guided treatment strategies for rheumatoid arthritis (DOC 42 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Østergaard, M., Møller-Bisgaard, S. Is imaging needed to define remission in rheumatoid arthritis?. Nat Rev Rheumatol 10, 326–328 (2014). https://doi.org/10.1038/nrrheum.2014.63

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2014.63

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing